HSL Mobile App 
52 week Low
1,515.50
1,515.50
52 week High
2,318.30
2,318.30
1525.20
Day low
1,515.50
1,515.50
Day high
1,574
1,574
1525.20
Prev Close
1,584.55
1,584.55
Open
1,574.00
1,574.00
6M return
-30.42%
-30.42%
1Y return
-11.51%
-11.51%
MCap(Rs. in Cr.)
8,023.19
8,023.19
Total Volume
88,061
88,061
Face Value : 2
Listed Since 15 Apr 2019
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
52.63052
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
29.69
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
6.61
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
61.89%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.26
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
1599.05
1599.05
Resistance 2
1613.55
1613.55
Support 1
1563.85
1563.85
Support 2
1543.15
1543.15
Moving Average
20 Days
1609.67
1609.67
50 Days
1704.37
1704.37
100 Days
1895.25
1895.25
200 Days
1998.39
1998.39
Growth in 3 years
Sales
-1.68%
Sales Industry Avg
4.63%
PAT
-40.16%
PAT Industry Avg
6.30%
-1.68%
Sales Industry Avg
4.63%
PAT
-40.16%
PAT Industry Avg
6.30%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 322.77 | 349.79 | 313.36 | 331 | 1,207.71 |
| Gross Profit | 70.03 | 88.21 | 76.62 | 76.95 | 269.16 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 42.66 | 62.12 | 51.58 | 50.43 | 174.69 |
| Tax | 11.19 | 15.42 | 13.47 | 13.90 | 46.23 |
| Profit After Tax | 31.47 | 46.70 | 38.11 | 36.53 | 128.46 |
Growth in 3 years
Total Asset Growth
3.36%
Total Liabilities growth
2.34%
Reserves Change
23.97%
3.36%
Total Liabilities growth
2.34%
Reserves Change
23.97%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2020 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 10.25 | 10.24 | 10.23 | 10.22 | 10.13 |
| Reserves And Surplus | 1,085.91 | 977.99 | 875.96 | 696.38 | 513.37 |
| Investments | 54.83 | 14.81 | 15.51 | 10.08 | 14.32 |
| Total Debt | 197.06 | 266.38 | 378.56 | 112.27 | 66.70 |
| Total Liabilities | 1,296.34 | 1,257.09 | 1,266.72 | 820.33 | 591.86 |
| Total Assets | 1,259.35 | 1,220.62 | 1,218.42 | 795.63 | 561.79 |
400%
Dividend
Date:23 Feb 2023
Dividend Percentage:400
Dividend Type:Interim
200%
Dividend
Date:17 Nov 2023
Dividend Percentage:200
Dividend Type:Interim
2023
2024 2025
2026
Relative to Sensex rtn in 3 year
-172.02%
Relative to Nifty rtn in 3 year
-166.78%
Relative to top 3 MF rtn in 3 year
-172.02%
Relative to Nifty rtn in 3 year
-166.78%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Metropolis Healt | -12 | 27 | -23 |
| Bse Sensex | 3 | 32 | 32 |
| Nifty 50 | 4 | 37 | 35 |
| Nifty 500 | 4 | 48 | 44 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Metropolis Healt
1525.20 chg : -59.35 (-3.75%)
1525.20 chg : -59.35 (-3.75%)
Max Healthcare
1083.60 chg : -45.80 (-4.06%)
1083.60 chg : -45.80 (-4.06%)
Apollo Hospitals
6632.30 chg : 140.25 (2.16%)
6632.30 chg : 140.25 (2.16%)
Fortis Health.
688.65 chg : 16.85 (2.51%)
688.65 chg : 16.85 (2.51%)
Narayana Hrudaya
1676.80 chg : 3.40 (0.20%)
1676.80 chg : 3.40 (0.20%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 88,489.20 with a Loss of -11.51%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Institutional Reports 06 Feb 2025 7:22 AM
Titan: Consolidated jewellery sales (ex-bullion) grew 27.3% YoY to INR159.9bn (in-line) powered by gold prices growth (up 25% YoY). Domestic jewellery (ex-bullion) grew 25.4% YoY. Secondary UCP/LTL g..
Institutional Reports 14 Jan 2025 1:51 PM
The India Pharma & Healthcare sector is expected to see steady growth in Q3FY25E. We project sales/EBITDA growth of 11%/13% YoY for our coverage universe. Our assumptions are: (1) pharma coverage wil..
Institutional Reports 11 Dec 2024 9:34 AM
Metropolis signed a definite agreement to acquire a 100% stake in Core Diagnostics. This acquisition will strengthen its advanced cancer testing capabilities and its footprint in the North and East r..
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
D
Dividend
Date:23 Feb 2023
Dividend Percentage:400
D
2023 Dividend
Date:17 Nov 2023
Dividend Percentage:200
2024
2025
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
| No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Metropolis Healthcare grants 18,000 RSUs
Metropolis Healthcare has granted 18,000 RSUs under the Metropolis � Restrictive Stock Unit Plan, 2020 to the eligible employee(s) of the Company on 1....
17 Mar 2025 15:45Metropolis Healthcare consolidated net profit rises 15.46% in the December 2024 quarter
Net profit of Metropolis Healthcare rose 15.46% to Rs 31.36 crore in the quarter ended December 2024 as against Rs 27.16 crore during the previous qua....
05 Feb 2025 07:31Metropolis Healthcare appoints Sameer Patel as Chief Financial Officer
Metropolis Healthcare has allotted Sameer Patel as Chief Financial Officer and Key Managerial Personnel of the Company effective from 10 February 202....
04 Feb 2025 18:26Metropolis Healthcare to discuss results
Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live N....
29 Jan 2025 17:19Metropolis Healthcare consolidated net profit rises 31.23% in the September 2024 quarter
Net profit of Metropolis Healthcare rose 31.23% to Rs 46.52 crore in the quarter ended September 2024 as against Rs 35.45 crore during the previous qu....
09 Nov 2024 07:39Metropolis Healthcare consolidated net profit rises 31.77% in the June 2024 quarter
Net profit of Metropolis Healthcare rose 31.77% to Rs 37.95 crore in the quarter ended June 2024 as against Rs 28.80 crore during the previous quarter....
12 Aug 2024 07:30__heading__
Published on __date__ at __time__
__description__
